AAAAAA
Results:
1-14
|
Results: 14
Authors:
Claesson, K
Brattstrom, C
Burke, JT
Citation: K. Claesson et al., Sirolimus and erythromycin interaction: Two cases, TRANSPLAN P, 33(3), 2001, pp. 2136-2136
Authors:
Johnson, RWG
Kreis, H
Oberbauer, R
Brattstrom, C
Claesson, K
Eris, J
Citation: Rwg. Johnson et al., Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure., TRANSPLANT, 72(5), 2001, pp. 777-786
Authors:
Vincenti, F
Ramos, E
Brattstrom, C
Cho, S
Ekberg, H
Grinyo, J
Johnson, R
Kuypers, D
Stuart, F
Khanna, A
Navarro, M
Nashan, B
Citation: F. Vincenti et al., Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation, TRANSPLANT, 71(9), 2001, pp. 1282-1287
Authors:
Bottiger, Y
Sawe, J
Brattstrom, C
Tollemar, J
Burke, JT
Hass, G
Zimmerman, JJ
Citation: Y. Bottiger et al., Pharmacokinetic interaction between single oral doses of ditiazem and sirolimus in healthy volunteers, CLIN PHARM, 69(1), 2001, pp. 32-40
Authors:
Wilczek, HE
Brattstrom, C
Citation: He. Wilczek et C. Brattstrom, Hematologic malignancies following organ transplantation, HEMAT BLOOD, 40, 2001, pp. 11-14
Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers
Authors:
Brattstrom, C
Sawe, J
Jansson, B
Lonnebo, A
Nordin, J
Zimmerman, JJ
Burke, JT
Groth, CG
Citation: C. Brattstrom et al., Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers, THER DRUG M, 22(5), 2000, pp. 537-544
Authors:
Kreis, H
Cisterne, JM
Land, W
Wramner, L
Squifflet, JP
Abramowicz, D
Campistol, JM
Morales, JM
Grinyo, JM
Mourad, G
Berthoux, FC
Brattstrom, C
Lebranchu, Y
Vialtel, P
Citation: H. Kreis et al., Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients, TRANSPLANT, 69(7), 2000, pp. 1252-1260
Authors:
Bottiger, Y
Brattstrom, C
Tyden, G
Sawe, J
Groth, CG
Citation: Y. Bottiger et al., Tacrolimus whole blood concentrations correlate closely to side-effects inrenal transplant recipients, BR J CL PH, 48(3), 1999, pp. 445-448
Authors:
Svensson, JO
Brattstrom, C
Sawe, J
Citation: Jo. Svensson et al., A simple HPLC method for simultaneous determination of mycophenolic acid and mycophenolic acid glucuronide in plasma, THER DRUG M, 21(3), 1999, pp. 322-324
Authors:
Vincenti, F
Grinyo, J
Ramos, E
Nashan, B
Stuart, F
Kuypers, D
Brattstrom, C
Cho, S
Ekberg, H
Johnson, R
Citation: F. Vincenti et al., Can antibody prophylaxis allow sparing of other immunosuppressives?, TRANSPLAN P, 31(1-2), 1999, pp. 1246-1248
Authors:
Groth, CG
Backman, L
Morales, JM
Calne, R
Kreis, H
Lang, P
Touraine, JL
Claesson, K
Campistol, JM
Durand, D
Wramner, L
Brattstrom, C
Charpentier, B
Citation: Cg. Groth et al., Sirolimus (rapamycin)-based therapy in human renal transplantation - Similar efficacy and different toxicity compared with cyclosporine, TRANSPLANT, 67(7), 1999, pp. 1036-1042
Authors:
Tyden, G
Bolinder, J
Solders, G
Brattstrom, C
Tibell, A
Groth, CG
Citation: G. Tyden et al., Improved survival in patients with insulin-dependent diabetes mellitus andend-stage diabetic nephropathy 10 years after combined pancreas and kidneytransplantation., TRANSPLANT, 67(5), 1999, pp. 645-648
Authors:
Brattstrom, C
Wilczek, HE
Tyden, G
Bottiger, Y
Sawe, J
Groth, CG
Citation: C. Brattstrom et al., Hypertriglyceridemia in renal transplant recipients treated with sirolimus, TRANSPLAN P, 30(8), 1998, pp. 3950-3951
New trails in transplantation: How to exploit the potential of sirolimus in clinical transplantation
Authors:
Groth, CG
Brattstrom, C
Claesson, K
Backman, L
Citation: Cg. Groth et al., New trails in transplantation: How to exploit the potential of sirolimus in clinical transplantation, TRANSPLAN P, 30(8), 1998, pp. 4064-4065
Risultati:
1-14
|